NIFFENEGGER KATHI 4
4 · Edesa Biotech, Inc. · Filed Apr 26, 2021
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-22+80,000→ 80,000 totalExercise: $5.45Exp: 2031-04-22→ Common Shares (80,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in equal proportions over 36 months beginning on the Grant Date.